Drug intelligence / Profile preview

gramicidin A

Development stage
Unknown
Modality
Peptides
Administration
Topical
01

Overview

Gramicidin A is a linear pentadecapeptide antibiotic originally derived from the soil bacterium *Bacillus brevis*. It is a well-characterized channel-forming ionophore that functions by inserting into lipid bilayers to form a dimeric nanopore. This pore selectively permits the rapid passage of monovalent cations, such as potassium (K+) and sodium (Na+), across the plasma membrane. The resulting disruption of transmembrane ion gradients leads to cellular energy depletion, loss of membrane potential, and subsequent cell death. While traditionally used as a topical antimicrobial agent (often as part of the gramicidin complex in combination with other antibiotics), research has explored its potential as an anticancer therapeutic. Specifically, preclinical studies have demonstrated that gramicidin A can induce energy depletion and apoptosis in renal cell carcinoma (RCC) cells, regardless of histological subtype or genetic markers like VHL expression.

Other names
Gramicidin A1Gramicidin A2

Beyond the preview

Go deeper on gramicidin A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gramicidin A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call